• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大肠杆菌中具有生物活性的β-半乳糖苷酶包涵体的形成。

The formation of biologically active beta-galactosidase inclusion bodies in Escherichia coli.

作者信息

Worrall D M, Goss N H

机构信息

Biotechnology Australia Pty Ltd.

出版信息

Aust J Biotechnol. 1989 Jan;3(1):28-32.

PMID:2485330
Abstract

Culture conditions affecting the formation of beta-galactosidase inclusion bodies in E. coli were examined. High temperature, early induction, high salt concentration and low aeration were all found to favour an increase of insoluble beta-galactosidase and the formation of visible inclusion bodies. The ratio of soluble to insoluble beta-galactosidase decreased during the course of cell growth. When assayed for beta-galactosidase activity, the inclusion bodies were enzymatically active with a specific activity of one third that of soluble beta-galactosidase. The activity remained associated with the inclusion bodies on washing with detergent and high ionic strength buffers. These results suggest that inclusion bodies can contain correctly folded protein.

摘要

研究了影响大肠杆菌中β-半乳糖苷酶包涵体形成的培养条件。发现高温、早期诱导、高盐浓度和低通气量均有利于不溶性β-半乳糖苷酶的增加和可见包涵体的形成。在细胞生长过程中,可溶性β-半乳糖苷酶与不溶性β-半乳糖苷酶的比例下降。当检测β-半乳糖苷酶活性时,包涵体具有酶活性,比活性为可溶性β-半乳糖苷酶的三分之一。在用去污剂和高离子强度缓冲液洗涤时,活性仍与包涵体相关。这些结果表明包涵体可以包含正确折叠的蛋白质。

相似文献

1
The formation of biologically active beta-galactosidase inclusion bodies in Escherichia coli.大肠杆菌中具有生物活性的β-半乳糖苷酶包涵体的形成。
Aust J Biotechnol. 1989 Jan;3(1):28-32.
2
Enhanced enzyme activities of inclusion bodies of recombinant beta-galactosidase via the addition of inducer analog after L-arabinose induction in the araBAD promoter system of Escherichia coli.在大肠杆菌araBAD启动子系统中,经L-阿拉伯糖诱导后添加诱导剂类似物,增强重组β-半乳糖苷酶包涵体的酶活性。
J Microbiol Biotechnol. 2008 Mar;18(3):434-42.
3
Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.在大肠杆菌中作为包涵体表达的重组人淋巴毒素(肿瘤坏死因子β)的纯化与复性
J Chem Technol Biotechnol. 1994 Jan;59(1):67-72. doi: 10.1002/jctb.280590111.
4
Expression of aggregation-prone recombinant proteins at low temperatures: a comparative study of the Escherichia coli cspA and tac promoter systems.低温下易于聚集的重组蛋白的表达:大肠杆菌cspA和tac启动子系统的比较研究
Protein Expr Purif. 1997 Mar;9(2):211-8. doi: 10.1006/prep.1996.0678.
5
Divergent effects of chaperone overexpression and ethanol supplementation on inclusion body formation in recombinant Escherichia coli.伴侣蛋白过表达和乙醇添加对重组大肠杆菌中包涵体形成的不同影响。
Protein Expr Purif. 1997 Dec;11(3):289-96. doi: 10.1006/prep.1997.0796.
6
Penicillin-binding protein 2a of Streptococcus pneumoniae: expression in Escherichia coli and purification and refolding of inclusion bodies into a soluble and enzymatically active enzyme.肺炎链球菌青霉素结合蛋白2a:在大肠杆菌中的表达以及包涵体的纯化和重折叠为可溶性且具有酶活性的酶
Protein Expr Purif. 1999 Jul;16(2):331-9. doi: 10.1006/prep.1999.1080.
7
Structural and functional studies on the interaction of sodium dodecyl sulfate with beta-galactosidase.十二烷基硫酸钠与β-半乳糖苷酶相互作用的结构与功能研究
Arch Biochem Biophys. 1993 Jan;300(1):451-7. doi: 10.1006/abbi.1993.1061.
8
Membrane docking of an aggregation-prone protein improves its solubilization.
Gene. 2008 Dec 15;426(1-2):32-8. doi: 10.1016/j.gene.2008.08.020. Epub 2008 Sep 9.
9
Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.在大肠杆菌中作为包涵体产生的治疗性蛋白质的复性。
Biopolymers. 1999;51(4):297-307. doi: 10.1002/(SICI)1097-0282(1999)51:4<297::AID-BIP5>3.0.CO;2-I.
10
Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.重组人可溶性II型转化生长因子-β受体在毕赤酵母和大肠杆菌中的表达:两种表达转化生长因子-β有效抑制剂的强大系统。
Protein Expr Purif. 1998 Mar;12(2):201-7. doi: 10.1006/prep.1997.0819.

引用本文的文献

1
From sequence to activity: the HgaI-homologous restriction modification system RM.MhoVI of Mycoplasma hominis.从序列到活性:人型支原体的HgaI同源限制修饰系统RM.MhoVI
BMC Microbiol. 2025 Aug 25;25(1):543. doi: 10.1186/s12866-025-04270-3.
2
A new Bowman-Birk type protease inhibitor regulated by MeJA pathway in maize exhibits anti-feedant activity against the Ostrinia furnacalis.玉米中茉莉酸甲酯途径调控的一种新型 Bowman-Birk 型蛋白酶抑制剂对玉米螟具有抗营养活性。
Plant Mol Biol. 2024 Oct 3;114(5):110. doi: 10.1007/s11103-024-01506-0.
3
Eukaryotic Aggresomes: Protocols and Tips for Their Production, Purification , and Handling.
真核生物聚集物:生产、纯化和处理的方案及技巧。
Methods Mol Biol. 2022;2406:417-435. doi: 10.1007/978-1-0716-1859-2_25.
4
Coiled-Coil Based Inclusion Bodies and Their Potential Applications.基于卷曲螺旋的包涵体及其潜在应用。
Front Bioeng Biotechnol. 2021 Aug 17;9:734068. doi: 10.3389/fbioe.2021.734068. eCollection 2021.
5
Thermostable adenosine 5'-monophosphate phosphorylase from Thermococcus kodakarensis forms catalytically active inclusion bodies.来自嗜热球菌的热稳定腺苷 5'-单磷酸磷酸化酶形成催化活性包含体。
Sci Rep. 2021 Aug 19;11(1):16880. doi: 10.1038/s41598-021-96073-5.
6
Catalytically-active inclusion bodies for biotechnology-general concepts, optimization, and application.用于生物技术的具有催化活性的包涵体——一般概念、优化及应用
Appl Microbiol Biotechnol. 2020 Sep;104(17):7313-7329. doi: 10.1007/s00253-020-10760-3. Epub 2020 Jul 10.
7
Structure-Function Relationship of Inclusion Bodies of a Multimeric Protein.多聚体蛋白包涵体的结构-功能关系
Front Microbiol. 2020 May 8;11:876. doi: 10.3389/fmicb.2020.00876. eCollection 2020.
8
Enzyme Assembly for Compartmentalized Metabolic Flux Control.用于区室化代谢通量控制的酶组装
Metabolites. 2020 Mar 26;10(4):125. doi: 10.3390/metabo10040125.
9
Directed evolution of a genetically encoded immobilized lipase for the efficient production of biodiesel from waste cooking oil.用于从废弃食用油高效生产生物柴油的基因编码固定化脂肪酶的定向进化。
Biotechnol Biofuels. 2019 Jun 28;12:165. doi: 10.1186/s13068-019-1509-5. eCollection 2019.
10
Perspectives of inclusion bodies for bio-based products: curse or blessing?生物基产品包涵体的观点:是祸还是福?
Appl Microbiol Biotechnol. 2019 Feb;103(3):1143-1153. doi: 10.1007/s00253-018-9569-1. Epub 2018 Dec 19.